Celgene Archives - Pharmaphorum

Celgene scores at ASH18 with double luspatercept data

https://pharmaphorum.com/news/celgene-scores-at-ash18-with-double-luspatercept-data/

Celgene plans filing for Revlimid/rituximab in lymphoma

https://pharmaphorum.com/news/celgene-plans-filing-for-revlimid-rituximab-in-lymphoma/

Novartis ranked top for corporate reputation in dermatology

https://pharmaphorum.com/news/novartis-corporate-reputation-dermatology/

ASCO 2018 Preview – what to expect from this year’s conference

https://pharmaphorum.com/views-and-analysis/asco-2018-preview-conference/

Evotec and Celgene unite to drive forward oncology R&D

https://pharmaphorum.com/news/evotec-celgene-unite-drive-forward-oncology-rd/

Ozanimod launch delayed by failures in FDA application

https://pharmaphorum.com/news/ozanimod-launch-delayed-by-failures-in-fda-application/

Celgene’s COO quits after troubles with new drugs

https://pharmaphorum.com/oncology/celgenes-coo-quits-troubles-new-drugs/

Celgene pursues neuro breakthrough with $150m Prosena deal

https://pharmaphorum.com/news/celgene-pursues-neuro-breakthrough-150m-prosena-deal/

Celgene to tackle ‘undruggable’ targets with Vividion

https://pharmaphorum.com/news/celgene-to-tackle-undruggable-targets-with-vividion/

Search